background
type
interferon
induc
mxa
respons
differenti
viral
bacteri
infect
mxa
respons
rhinoviru
asymptomat
viru
infect
known
object
studi
mxa
protein
level
healthi
state
respiratori
viru
infect
young
children
observ
prospect
cohort
studi
design
blood
sampl
nasal
swab
collect
children
without
symptom
respiratori
infect
respect
blood
mxa
protein
level
measur
enzym
immunoassay
pcr
method
use
detect
respiratori
virus
nasal
swab
result
respiratori
virus
detect
symptomat
children
higher
blood
mxa
protein
level
median
interquartil
rang
asymptomat
virusneg
children
gl
vs
gl
p
within
asymptomat
children
signific
differ
observ
mxa
respons
virusposit
virusneg
group
cutoff
level
gl
sensit
specif
symptomat
respiratori
viru
infect
rhinoviru
respiratori
syncyti
viru
parainfluenza
viru
influenza
viru
coronaviru
human
metapneumoviru
infect
associ
elev
mxa
respons
asymptomat
virusneg
children
vaccin
live
viru
vaccin
elev
mxa
protein
level
gl
significantli
lower
children
acut
respiratori
infect
receiv
vaccin
gl
p
conclus
blood
mxa
protein
level
increas
young
children
symptomat
respiratori
viru
infect
includ
rhinoviru
infect
mxa
inform
gener
marker
common
acut
viru
infect
respiratori
tract
infect
rti
caus
high
diseas
burden
children
develop
countri
major
caus
mortal
develop
countri
surrog
marker
viru
infect
would
use
guid
antimicrobi
therapi
decis
discrimin
viru
infect
inflammatori
condit
myxoviru
resist
protein
mxa
intracellular
cytoplasm
gtpase
activ
wide
rang
virus
induc
exclus
type
iii
interferon
ifn
specif
respons
viru
infect
basal
level
healthi
immunotoler
individu
low
halflif
blood
leukocyt
day
level
remain
elev
shortli
acut
infect
although
sever
differ
virus
induc
mxa
express
controversi
concern
mxa
respons
rhinoviru
rv
still
exist
rv
frequent
caus
rti
children
adult
determin
mxa
respons
rv
infect
would
critic
potenti
use
sensit
marker
viru
infect
compar
blood
mxa
protein
level
young
children
respiratori
infect
caus
rv
respiratori
virus
asymptomat
virusneg
children
also
studi
whether
mxa
respons
symptomat
respiratori
viru
infect
differenti
respons
asymptomat
infect
immun
studi
conduct
within
prospect
observ
birthcohort
studi
step
healthi
develop
wellb
children
step
recruit
children
follow
intens
rti
first
two
year
life
februari
april
blood
sampl
mxa
creactiv
protein
crp
determin
white
blood
cell
count
wbc
collect
children
month
age
present
studi
clinic
symptom
acut
rti
fever
ill
appear
exist
durat
symptom
rhinorrhoea
cough
wheez
fever
symptom
find
clinic
examin
uniformli
document
fever
defin
bodi
temperatur
c
per
rectum
c
axilla
tympan
membran
famili
encourag
visit
studi
clinic
children
experienc
symptom
rti
altern
train
parent
collect
nasal
swab
children
home
mail
specimen
studi
clinic
blood
sampl
mxa
nasal
swab
virus
collect
also
children
schedul
visit
studi
clinic
age
month
blood
sampl
mxa
collect
asymptomat
parent
possibl
presenc
respiratori
symptom
document
schedul
visit
identifi
true
asymptomat
children
children
often
mild
respiratori
symptom
without
respiratori
symptom
neg
respiratori
virus
serv
control
group
uninfect
asymptomat
children
sampl
collect
differ
time
point
child
analyz
separ
case
childhood
vaccin
histori
collect
electron
registri
region
well
babi
clinic
vaccin
administ
child
day
preced
mxa
sampl
includ
analysi
mxa
protein
level
determin
enzym
immunoassay
eia
capillari
whole
blood
sampl
taken
fingertip
prick
children
visit
rti
peripher
venou
whole
blood
sampl
taken
antecubit
venipunctur
schedul
visit
blood
sampl
dilut
hypoton
buffer
store
c
eia
perform
describ
supplementari
data
earlier
studi
crp
wbc
measur
capillari
whole
blood
sampl
rapid
crp
test
perform
orion
quikread
orion
diagnostica
espoo
finland
rapid
wbc
count
done
use
hemocu
wbc
hemocu
sweden
pointofcar
analys
accord
manufactur
instruct
nasal
swab
suspend
phosphat
buffer
salin
subject
autom
nucleic
acid
extract
use
nuclisens
easymag
biomerieux
boxtel
netherland
magnapur
roch
penzberg
germani
instrument
extract
rna
revers
transcrib
cdna
amplifi
use
realtim
pcr
rv
enteroviru
respiratori
syncyti
viru
rsv
describ
earlier
modif
primer
forward
revers
probe
lock
nucleic
acid
analog
specif
rsv
f
gene
includ
assay
seeplex
multiplex
pcr
assay
seegen
seoul
korea
rv
rsva
rsvb
adenoviru
adv
influenza
flu
b
virus
parainfluenza
viru
piv
type
human
metapneumoviru
hmpv
coronavirus
cov
perform
accord
manufactur
instruct
separ
pcr
test
use
detect
human
bocaviru
hbov
rv
rsv
posit
result
either
one
test
consid
posit
test
result
mannwhitney
u
test
use
compar
blood
mxa
protein
level
test
fisher
exact
test
use
categor
data
kruskalw
test
use
multipl
comparison
follow
pairwis
mannwhitney
u
test
bonferroni
correct
decis
threshold
mxa
calcul
receiv
oper
characterist
roc
analysi
correl
blood
mxa
viral
load
durat
symptom
calcul
spearman
correl
p
valu
consid
statist
signific
statist
analys
perform
use
ibm
spss
statist
macintosh
version
total
number
blood
sampl
collect
children
studi
clinic
visit
acut
rti
blood
sampl
mxa
crp
wbc
determin
collect
children
nine
children
exclud
studi
miss
nasal
swab
bacteri
infect
children
cultur
confirm
pyelonephr
orbit
cellul
mxa
crp
level
gl
mgl
gl
mgl
gl
mgl
respect
result
group
children
visit
rti
tabl
blood
mxa
also
measur
children
schedul
visit
age
n
month
n
children
symptom
respiratori
infect
time
sampl
collect
addit
blood
mxa
level
determin
asymptomat
parent
age
year
male
clinic
laboratori
viru
find
studi
subject
present
tabl
roc
analysi
use
estim
abil
mxa
differenti
children
laboratoryconfirm
symptomat
respiratori
viru
infect
asymptomat
virusneg
children
greatest
sum
sensit
specif
obtain
cutoff
level
gl
upper
limit
normal
rang
slighli
lower
specif
obtain
comparison
group
asymptomat
children
regardless
viru
detect
blood
mxa
protein
level
children
accord
presenc
respiratori
symptom
viru
detect
asymptomat
adult
shown
fig
basal
level
blood
mxa
median
interquartil
rang
significantli
higher
asymptomat
children
asymptomat
adult
gl
vs
gl
p
mxa
protein
level
differ
asymptomat
children
month
compar
month
age
gl
vs
gl
p
children
symptomat
laboratori
confirm
respiratori
viru
infect
higher
mxa
level
asymptomat
virusneg
children
mxa
level
weak
neg
correl
durat
symptom
preced
sampl
assay
sensit
affect
fig
symptomat
rv
rsv
piv
flu
cov
hmpv
infect
associ
elev
mxa
level
wherea
mxa
level
hbov
infect
children
found
differ
p
asymptomat
viru
neg
children
fig
mxa
level
children
posit
one
viru
similar
seen
children
posit
one
viru
gl
vs
gl
p
signific
correl
rv
rsv
rna
copi
number
blood
mxa
level
rv
log
copi
vs
mxa
spearman
rho
p
rsv
log
copi
vs
mxa
spearman
rho
p
sampl
avail
children
healthi
asymptomat
state
later
respiratori
infect
demonstr
individu
mxa
respons
signific
differ
state
fig
studi
symptomat
infect
caus
common
respiratori
virus
includ
rv
associ
elev
mxa
level
blood
accord
previou
studi
mxa
induc
influenza
parainfluenza
rs
adenoviru
infect
children
capabl
rv
induc
mxa
protein
express
controversi
vitro
anim
experi
show
rv
infect
abl
induc
type
ifn
respons
thu
would
expect
mxa
ifninduc
protein
would
also
induc
howev
earlier
flow
cytometr
analysi
isol
blood
lymphocyt
show
weak
mxa
respons
rv
patient
adult
sever
infect
presenc
fever
specifi
discrep
result
may
explain
differ
clinic
setup
differ
methodolog
use
appar
milder
rv
infect
adult
current
studi
mxa
measur
whole
blood
lysat
eia
less
timeconsum
potenti
rapid
diagnost
use
use
gl
cutoff
level
elev
mxa
sensit
specif
symptomat
respiratori
viru
infect
suggest
mxa
use
marker
respiratori
viru
infect
children
earlier
mxa
shown
discrimin
viral
bacteri
infect
febril
children
number
investig
respiratori
virus
studi
limit
present
studi
blood
cell
mxa
level
significantli
elev
asymptomat
virusposit
children
compar
asymptomat
virusneg
children
present
studi
provid
evid
discriminatori
power
blood
mxa
protein
differenti
viral
nonvir
caus
febril
infect
viral
coinfect
common
children
diagnos
sensit
pcr
assay
controversi
whether
infect
multipl
virus
caus
sever
diseas
compar
infect
caus
singl
viru
furthermor
higher
viral
load
may
associ
caus
role
viru
ill
sever
symptom
coinfect
high
viral
load
singl
viru
infect
associ
higher
mxa
level
studi
howev
detail
studi
immun
respons
condit
well
mxa
respons
viralbacteri
coinfect
warrant
low
detect
number
investig
virus
limit
gener
data
presenc
hbov
dna
nasal
secret
associ
elev
mxa
level
five
case
hbov
sole
viru
may
preclud
definit
conclus
whether
hbov
abl
abl
induc
type
ifn
mxa
respons
although
analyz
virus
pcr
addit
virus
eg
piv
type
includ
assay
could
explain
symptom
children
neg
pcr
result
still
viru
detect
rate
symptomat
subject
high
outofhospit
studi
children
sole
bacteri
infect
note
low
mxa
protein
level
gl
schedul
visit
step
studi
includ
antecubit
venipunctur
collect
peripher
venou
whole
blood
sampl
separ
laboratori
work
studi
child
visit
clinic
rti
capillari
whole
blood
sampl
taken
fingertip
prick
chieux
cowork
observ
excel
correl
lower
mxa
level
capillari
blood
compar
venou
blood
mxa
level
respiratori
infect
capillari
blood
significantli
higher
healthi
state
venou
blood
indic
strong
mxa
respons
produc
viru
infect
exce
minor
differ
caus
differ
sampl
type
recent
immun
live
viru
vaccin
case
rotaviru
vaccin
associ
increas
mxa
level
inactiv
vaccin
effect
find
line
studi
roer
et
al
show
mxa
protein
induc
healthi
volunt
immun
live
yellow
fever
viru
vaccin
data
suggest
recent
vaccin
live
viru
vaccin
taken
consider
interpret
mxa
result
conclus
studi
demonstr
blood
mxa
level
increas
young
children
symptomat
respiratori
viru
infect
includ
rv
infect
detect
mxa
protein
blood
leucocyt
reconsid
broadspectrum
diagnost
marker
respiratori
viru
infect
young
children
none
declar
ethic
committe
hospit
district
southwest
finland
approv
studi
parent
particip
children
gave
written
inform
consent
